Biocatalytic synthesis of 4-pregnen-20,21-diol-3-one, a selective inhibitor of human 5α-reductase type II

By Hannemann Frank   Bernhardt Rita   Jose Joachim  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 22, Iss. 5, 2007-10 ,pp. : 570-576

Informa Healthcare

Access to resources Recommend Favorite

Differential Membrane Antioxidant Effects of Immediate and Long-Term Estradiol Treatment of MCF-7 Breast Cancer Cells

By Schor N.F.   Tyurina Y.Y.   Tyurin V.A.   Kagan V.E.  

Biochemical and Biophysical Research Communications, Vol. 260, Iss. 2, 1999-07 ,pp. : 410-415

Elsevier

Access to resources Recommend Favorite

Increased levels of tyrosinated α-, β_III-, and β_IV-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells

By Banerjee A.  

Biochemical and Biophysical Research Communications, Vol. 293, Iss. 1, 2002-04 ,pp. : 598-601

Elsevier

Access to resources Recommend Favorite

A Soluble Dominant Negative Fibroblast Growth Factor Receptor 4 Isoform in Human MCF-7 Breast Cancer Cells

By Ezzat S.   Zheng L.   Yu S.   Asa S.L.  

Biochemical and Biophysical Research Communications, Vol. 287, Iss. 1, 2001-09 ,pp. : 60-65

Elsevier

Access to resources Recommend Favorite

Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer Cells

By Nickerson T.   Huynh H.   Pollak M.  

Biochemical and Biophysical Research Communications, Vol. 237, Iss. 3, 1997-08 ,pp. : 690-693

Elsevier

Access to resources Recommend Favorite